rs11215416

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001301043.2(CADM1):​c.1078+2967T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 152,044 control chromosomes in the GnomAD database, including 3,564 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3564 hom., cov: 31)

Consequence

CADM1
NM_001301043.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.178

Publications

7 publications found
Variant links:
Genes affected
CADM1 (HGNC:5951): (cell adhesion molecule 1) Enables signaling receptor binding activity. Involved in several processes, including cell recognition; positive regulation of cytokine production; and susceptibility to natural killer cell mediated cytotoxicity. Located in plasma membrane. Implicated in breast carcinoma and prostate cancer. Biomarker of cervix uteri carcinoma in situ. [provided by Alliance of Genome Resources, Apr 2022]
CADM1 Gene-Disease associations (from GenCC):
  • autism spectrum disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CADM1NM_001301043.2 linkc.1078+2967T>C intron_variant Intron 8 of 11 ENST00000331581.11 NP_001287972.1 Q9BY67-3X5D7A8A0A4Z1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CADM1ENST00000331581.11 linkc.1078+2967T>C intron_variant Intron 8 of 11 1 NM_001301043.2 ENSP00000329797.6 Q9BY67-3

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29872
AN:
151926
Hom.:
3559
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0683
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.281
Gnomad ASJ
AF:
0.160
Gnomad EAS
AF:
0.143
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.272
Gnomad MID
AF:
0.213
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.186
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.197
AC:
29882
AN:
152044
Hom.:
3564
Cov.:
31
AF XY:
0.200
AC XY:
14823
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.0682
AC:
2831
AN:
41520
American (AMR)
AF:
0.281
AC:
4293
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.160
AC:
553
AN:
3466
East Asian (EAS)
AF:
0.143
AC:
736
AN:
5158
South Asian (SAS)
AF:
0.315
AC:
1516
AN:
4806
European-Finnish (FIN)
AF:
0.272
AC:
2870
AN:
10562
Middle Eastern (MID)
AF:
0.216
AC:
63
AN:
292
European-Non Finnish (NFE)
AF:
0.244
AC:
16566
AN:
67960
Other (OTH)
AF:
0.184
AC:
388
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1172
2343
3515
4686
5858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.212
Hom.:
754
Bravo
AF:
0.189
Asia WGS
AF:
0.222
AC:
773
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
14
DANN
Benign
0.70
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11215416; hg19: chr11-115077327; API